-
Je něco špatně v tomto záznamu ?
New trends in criteria indicative of neoadjuvant oncological therapy of lower and middle rectal cancers
Martin Kukucka, Ludovit Danihel, Milan Oravsky, Matus Rajcok, Michal Bernadic, Paula Kovarova, Natalie Birknerova, Marian Cerny, Maria Novisedlakova, Miriam Drahokoupilova, Peter Stefanik, Milan Schnorrer
Status minimální Jazyk angličtina Země Slovensko
The indication for primary surgical resection or neoadjuvant therapy in lower and middle rectal cancers is often disputable. The aim of the study was to evaluate the occurrence of local recurrence of rectal cancer as for a period of at least 4 years after radical resection. The second aim was to evaluate and compare the results of preoperative magnetic resonance (MR) staging with definitive histology. From September 2013 to December 2017, we, at the 3rd Surgical Department Comenius University, Bratislava, prospectively evaluated patients with lower and middle rectal cancers with the distal tumor border being in a 12-cm distance from the anal verge. All patients underwent MR examination at the same MRI department and were operated on at the 3rd Surgical Department, Comenius University, Bratislava. Inclusion criteria included parameters based on MRI examination, i.e., T-staging of T1-T3b, negative extramural vascular infiltration (EMVI), negative circumferential margin (CRM), no mesorectal fascia infiltration with a distance of more than 2 mm. We did not take lymph node staging into account in the indication for primary surgical resection. We performed a radical primary resection procedure (R0 resection) in all patients. The group consisted of 87 patients, of whom 49 were men and 38 were women. The mean age of the patients was 66 years (min. 36 – max. 86 years). Our study also shows significant differences in preoperative T and N staging as compared to definitive histology. The incidence of local recurrence during a period of at least 4 years after surgery was 6.76 %. Study also shows that the indication for preoperative radiotherapy for lower and middle rectal cancers based on N status is inaccurate and leads to unnecessary indications for preoperative radiotherapy which may decrease the patients ́ quality of life and increase the post‐operative complications. We have also shown that leaving out the N-based radiotherapy from indications does not lead to an increase in the number of local recurrences in lower and middle rectal cancers (Tab. 1, Fig. 5, Ref. 22).
2nd Department of Surgery Comenius University Bratislava Slovakia
3rd Department of Surgery Comenius University Bratislava Slovakia
Department of Clinical Oncology The Brothers of Saint John of God Bratislava Slovakia
Department of Surgical Oncology National Oncological Institute Bratislava Slovakia
Klinik fur Allgemein Viszeral Thorax Adipositas Gefäss und Kinderchirurgie Passau Germany
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23023162
- 003
- CZ-PrNML
- 005
- 20240109171147.0
- 007
- ta
- 008
- 240109s2023 xo d f 000 0|eng||
- 009
- AR
- 024 0_
- $a 10.4149/BLL_2023_086 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Kukučka, Martin $7 xx0257819 $u IIIrd Department of Surgery Comenius University Bratislava, Slovakia
- 245 10
- $a New trends in criteria indicative of neoadjuvant oncological therapy of lower and middle rectal cancers / $c Martin Kukucka, Ludovit Danihel, Milan Oravsky, Matus Rajcok, Michal Bernadic, Paula Kovarova, Natalie Birknerova, Marian Cerny, Maria Novisedlakova, Miriam Drahokoupilova, Peter Stefanik, Milan Schnorrer
- 504 __
- $a Literatura
- 520 9_
- $a The indication for primary surgical resection or neoadjuvant therapy in lower and middle rectal cancers is often disputable. The aim of the study was to evaluate the occurrence of local recurrence of rectal cancer as for a period of at least 4 years after radical resection. The second aim was to evaluate and compare the results of preoperative magnetic resonance (MR) staging with definitive histology. From September 2013 to December 2017, we, at the 3rd Surgical Department Comenius University, Bratislava, prospectively evaluated patients with lower and middle rectal cancers with the distal tumor border being in a 12-cm distance from the anal verge. All patients underwent MR examination at the same MRI department and were operated on at the 3rd Surgical Department, Comenius University, Bratislava. Inclusion criteria included parameters based on MRI examination, i.e., T-staging of T1-T3b, negative extramural vascular infiltration (EMVI), negative circumferential margin (CRM), no mesorectal fascia infiltration with a distance of more than 2 mm. We did not take lymph node staging into account in the indication for primary surgical resection. We performed a radical primary resection procedure (R0 resection) in all patients. The group consisted of 87 patients, of whom 49 were men and 38 were women. The mean age of the patients was 66 years (min. 36 – max. 86 years). Our study also shows significant differences in preoperative T and N staging as compared to definitive histology. The incidence of local recurrence during a period of at least 4 years after surgery was 6.76 %. Study also shows that the indication for preoperative radiotherapy for lower and middle rectal cancers based on N status is inaccurate and leads to unnecessary indications for preoperative radiotherapy which may decrease the patients ́ quality of life and increase the post‐operative complications. We have also shown that leaving out the N-based radiotherapy from indications does not lead to an increase in the number of local recurrences in lower and middle rectal cancers (Tab. 1, Fig. 5, Ref. 22).
- 700 1_
- $a Danihel, Ľudovít, $d 1988- $7 xx0269497 $u IIIrd Department of Surgery Comenius University Bratislava, Slovakia
- 700 1_
- $a Oravský, Milan $7 xx0169175 $u IIIrd Department of Surgery Comenius University Bratislava, Slovakia
- 700 1_
- $a Rajčok, Matúš $7 xx0169142 $u IIIrd Department of Surgery Comenius University Bratislava, Slovakia
- 700 1_
- $a Bernadič, Michal $7 xx0250568 $u Department of Surgical Oncology, National Oncological Institute, Bratislava, Slovakia
- 700 1_
- $a Kovarova, Paula $u IIIrd Department of Surgery Comenius University Bratislava, Slovakia
- 700 1_
- $a Birknerova, Natalie $u Department of Clinical Biochemistry Charles University, University Hospital in Hradec Králové Czech Republic
- 700 1_
- $a Cerny, Marian $u Klinik fur Allgemein-, Viszeral-, Thorax-, Adipositas-, Gefäss- und Kinderchirurgie, Passau, Germany
- 700 1_
- $a Novisedláková, Mária $7 xx0257821 $u Department of Clinical Oncology, The Brothers of Saint John of God, Bratislava, Slovakia
- 700 1_
- $a Drahokoupilová, Miriam $7 xx0182536 $u Department of Clinical Oncology, The Brothers of Saint John of God, Bratislava, Slovakia
- 700 1_
- $a Stefanik, Peter $u IInd Department of Surgery, Comenius University, Bratislava, Slovakia
- 700 1_
- $a Schnorrer, Milan, $d 1930- $7 nlk20010096863 $u IIIrd Department of Surgery Comenius University Bratislava, Slovakia
- 773 0_
- $t Bratislavské lekárske listy $x 0006-9248 $g Roč. 124, č. 8 (2023), s. 557-561 $w MED00000845
- 856 41
- $u http://www.elis.sk/download_file.php?product_id=8068&session_id=7cmce1hbsfsdgujb6b93572nv2 $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4 $c 1067 $y 0 $z 0
- 990 __
- $a 20240109132428 $b ABA008
- 991 __
- $a 20240109171144 $b ABA008
- 999 __
- $a min $b bmc $g 2033208 $s 1209613
- BAS __
- $a 3
- BMC __
- $a 2023 $b 124 $c 8 $d 557-561 $i 0006-9248 $m Bratislavské lekárske listy $x MED00000845 $n Bratisl Lek Listy
- LZP __
- $a NLK 2024-02/kv
